In amyotrophic lateral sclerosis, there is a need for biomarkers to distinguish patients from controls, to follow disease progression and to provide information about the pathogenesis of disease. In a

Taylor & Francis Group2021-05-06 更新10

Upregulation of inflammation-related genes in the blood of Huntington’s patients

神经退行性疾病生物标志物

血液基因表达谱分析

Blood is a very accessible tissue and as such constitutes a useful source of clinical markers. While it is obvious that metabolic disorders leave a clear mark in blood, it is not so clear whether this

NIAID Data Ecosystem50

Linear mixed effects models for RNFL-G thickness, RNFL-T thickness, and macular volume in the Huntington’s disease group with UHDR TMS and disease duration as fixed effects.

神经退行性疾病生物标志物

眼科图像分析

Linear mixed effects models for RNFL-G thickness, RNFL-T thickness, and macular volume in the Huntington’s disease group with UHDR TMS and disease duration as fixed effects.

NIAID Data Ecosystem20

Prodromal markers of PD in the prospective TREND study.

资源简介：

相关数据集